miR-324-5p acts as an independent prognostic biomarker and inhibits pediatric medulloblastoma progression by targeting HOXA9.
- DOI
- 10.1080/15257770.2026.2733331
- Published
- 2026 Sep 22
- Container
- Nucleosides, nucleotides & nucleic acids
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/15257770.2026.2733331,
title = {miR-324-5p acts as an independent prognostic biomarker and inhibits pediatric medulloblastoma progression by targeting HOXA9.},
author = {Wang S and Yang X and Sun Y and Wu W and Guo X and Cao X and Fang J},
year = {2026},
journal = {Nucleosides, nucleotides \& nucleic acids},
doi = {10.1080/15257770.2026.2733331},
url = {https://doi.org/10.1080/15257770.2026.2733331}
}RIS
TY - JOUR TI - miR-324-5p acts as an independent prognostic biomarker and inhibits pediatric medulloblastoma progression by targeting HOXA9. AU - Wang S AU - Yang X AU - Sun Y AU - Wu W AU - Guo X AU - Cao X AU - Fang J PY - 2026 JO - Nucleosides, nucleotides & nucleic acids DO - 10.1080/15257770.2026.2733331 UR - https://doi.org/10.1080/15257770.2026.2733331 ER -
APA
S, W., X, Y., Y, S., W, W., X, G., X, C., & J, F. (2026). miR-324-5p acts as an independent prognostic biomarker and inhibits pediatric medulloblastoma progression by targeting HOXA9.. Nucleosides, nucleotides & nucleic acids. https://doi.org/10.1080/15257770.2026.2733331
Source records
- pubmed · retrieved 2026-09-27T00:43:35.113Z